In Vitro Diagnostics in a Recessionary Economy.pdf
《In Vitro Diagnostics in a Recessionary Economy.pdf》由会员分享,可在线阅读,更多相关《In Vitro Diagnostics in a Recessionary Economy.pdf(119页珍藏版)》请在三一文库上搜索。
1、In Vitro Diagnostics in a Recessionary Economy May 2009 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media
2、now in existence or hereafter developed, in whole or in any part, is strictly prohibited IVD IN A RECESSIONARY ECONOMY In Vitro Diagnostics Markets in a Recessionary Economy has been prepared by Kalorama Information. We serve business and industrial clients in the United States and abroad with a com
3、plete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by providing a thorough presentation of essential data and concise analysis. Author: Shara Rosen Publication Date: May 2009 38
4、 East 29th Street New York, New York 10016 (800) 298-5699 Outside the U.S. (212) 807-2657 FAX: (212) 807-2676 www.KaloramaI E-MAIL: Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is st
5、rictly prohibited TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY1 Scope and Methodology .1 Market Trends.2 World Demand for Diagnostics4 Keys to Success.7 CHAPTER TWO: INTRODUCTION.11 Background.11 Marketing in a recession what the experts say about the 4Ps13 Obamas new deal boom and bust.15 Musin
6、gs on what form a reformed U.S. system might take19 Status quo and future impressing investors in a bear market.21 CHAPTER THREE: MARKET TRENDS/DEMAND ANALYSIS.27 Hospital Financing27 The role of the new deal for the insured, uninsured and underinsured30 Payer Response to Economic Stress.32 Demand f
7、or esoteric Tests 35 World demand for IVD Tests and Services36 United States of America40 Europe.42 Japan .44 China.45 CHAPTER FOUR: MARKET OVERVIEW/SUPPLY ANALYSIS49 Market Analysis, revenue estimates 20092014 49 IVD Sectors.52 IVD Events53 New Tests and Technologies53 Acquisitions, Mergers.56 Coll
8、aborations.59 Market Expansion Activities.60 Lab Services62 Lab Information Technology63 CHAPTER FIVE: COMPANY PROFILES.65 Abbott Diagnostics66 Atherotech.67 Beckman Coulter Inc68 Becton, Dickinson and Company (BD)70 bioMerieux Inc72 Celera Corporation74 Cellestis Ltd76 Cepheid.77 iv IVD in a Recess
9、ionary Economy Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Clarient Inc. (formerly ChromaVision)79 deCode Genetics Inc.80 Genomic Health81 Gen-Probe Inc.82 Imm
10、ucor, Inc.83 Inverness Medical Innovations.85 Luminex Corporation87 Monogram Biosciences, Inc89 Nanogen91 Ortho Clinical Diagnostics (OCD)93 Qiagen N.V.95 Quidel Corporation.97 Roche Diagnostics 98 Seegene, Inc100 Sequenom, Inc.101 Siemens Medical Solutions Diagnostics.103 Sysmex Corporation104 Verm
11、illion/Ciphergen Biosystems Inc106 CHAPTER SIX: CONCLUSION.107 Marketing Strategies for Now and the Future.107 Keep Your Pricing Stable.107 Strengthen the Marketing Budget.109 Evidence-Based Medicine is Here to Stay109 Conclusion110 Table of Contents v Copyright 2009 Kalorama Information Reproductio
12、n without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited TABLE OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY Figure 1-1: IVD Market 2009 and 2014.5 Figure 1-2: Growth Rates in Various Countries/Regions Compared.7 CHAPTER T
13、WO: INTRODUCTION Table 2-1: Selected IVD Venture Investments24 CHAPTER THREE: MARKET TRENDS/DEMAND ANALYSIS Table 3-1: Number of People Worldwide Who Get Chronic Diseases Every Year.35 Table 3-2: Percent Change in Industrial Productivity, by Country or Region,.37 Table 3-3: Worldwide In Vitro Diagno
14、stic Reagent Sales by Country, 2009-2014 40 Table 3-4: Europe Unemployment Rates and % change in GDP .43 CHAPTER FOUR: MARKET OVERVIEW/SUPPLY ANALYSIS Table 4-1: Worldwide In Vitro Diagnostic Reagent Sales by Product Market, 2009-2014 ($ million).50 CHAPTER SIX: CONCLUSION Table 6-1: Pricing Structu
15、res That Create Value for the Customer.108 Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited CHAPTER ONE Executive Summary SCOPE AND METHODOLOGY This report discusse
16、s some of the nuances of how our current economic conditions play out in marketing IVD products. It also presents actions that IVD companies can take to assure growth in uncertainty. The report focuses on developments at work in the United States since this is the largest single market for IVD produ
17、cts and also the epicenter of the economic meltdown that is having repercussions across the globe. The economic problems that began slowing the U.S. economy in the fall of 2007 keep spreading, with Europe and Japan following America into recession. The source of global economic woes and unemployment
18、 is partly related to Americas huge appetite for imported goods. With spending down so goes the market for imports. U.S. imports from China dropped 5% over the past year, a far cry from the recent rapid growth. But U.S. imports from Germany and Japan fell a whopping 12% and 19%, respectively. The re
19、port looks at the market for IVD products in the developed markets of North America, the European Union and Japan, and provides some insight to opportunities in emerging nations, primarily China, India, Asia and Latin America. Market analysis in this report covers world markets for in vitro diagnost
20、ics, however the reader will find a bias toward the developed areas of the globe - North America, Japan and Western Europe. However public health and infectious disease are a growing global problem and where possible the report covers IVD products related to the globalization of diseases. 2 IVD in a
21、 Recessionary Economy Copyright 2009 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited The information presented in this report is derived on publicly available information sources
22、 such as company, government, and medical organization reports. The analysis is based on the authors industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics, imaging industries and cardiologists. Major informati
23、on sources include but are not limited to the following: American Association for Clinical Chemistry, www.aacc.org EDMA (the European Diagnostic Manufacturers Association), www.edma-ivd.be FDA, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), www.fda.gov/cdrh/oivd/index.html Medica
24、l Test Kits Information Directory, www.medical-test- M, Reuters Healthcare, The Henry Kaiser Family Foundation, Daily Reports, www.kaisernetwork.org/Daily_Reports The Wall Street Journal, Health Edition Online, http:/ Yahoo Medical and Pharmaceutical News, http:/ MARKET TRENDS Compared to the aut
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- In Vitro Diagnostics Recessionary Economy
链接地址:https://www.31doc.com/p-3773417.html